Specifically, the expression of CD16-CD56 on NK T cells and HLA DR on CD33dim HLA DR+ CD11b+ cells exhibited a negative correlation with lung cancer, whereas the expression of HLA DR on CD33dim HLA DR+ CD11b+ cells was positively correlated with IL-18 and IL-13 levels. The gene discussed is NCAM1; the disease is lung carcinoma.